Physician profile
Sydney Smith
NPI 1194454611
$3,284.10
in general payments reported to CMS, 2019-2025
10 companies · $264 in 2025
The $264 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,297 · 2023: $1,379 · 2024: $345 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,988.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,987.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,210.26 | 2022-2023 | Mako, Blueprint Patient Specific Instrumentation, Hoffmann |
| Axogen | $427.54 | 2023-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Ha+ Nerve Protector |
| Sanara Medtech INC. | $147.93 | 2023 | Celleraterx |
| Amgen INC. | $147.69 | 2024 | Prolia, Evenity |
| Vertex Pharmaceuticals Incorporated | $121.79 | 2025 | |
| Depuy Synthes Sales INC. | $111.84 | 2023-2024 | Na, Tfn-Advance |
| Boston Scientific Corporation | $34.98 | 2023 | Varithena Administration Pack |
| Fx Shoulder Solutions, INC | $34.41 | 2024 | |
| Treace Medical Concepts, INC. | $24.42 | 2023 | |
| Ethicon US, LLC | $23.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sydney Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.